BPC-157 has been shown to upregulate epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), and nerve growth factor (NGF) expression in multiple rodent tissue models
BPC-157 promotes angiogenesis, creating new blood vessels that improve nutrient and oxygen delivery to healing tissues
We conducted a comprehensive search of MEDLINE, Embase, Scopus, and Cochrane CENTRAL, along with Google Scholar for additional internet sources, from their inception until December 2024 for randomized controlled trials of the effects of GLP-1 RAs on testosterone levels in men with functional hypogonadism
Pentadecapeptide BPC enhances the growth hormone receptor expression in tendon fibroblasts
Injection site reactions(redness or discomfort) No major adverse reactions have been reported in studies, but more research is needed to fully understand its safety profile